Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Perrigo (NY:PRGO)

22.91 +0.21 (+0.90%)
Streaming Delayed Price Updated: 11:48 AM EDT, Aug 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Perrigo

< Previous 1 2 3 4 Next >
Missed Opt-Out Deadline Could Cost Investors Millions In Perrigo Fraud Suit
Perrigo faces a legal battle over whether major investor Sculptor can exit a securities class action years after missing the opt-out deadline amid $1 billion restatements. 
Via Benzinga
Topics Fraud
Perrigo (PRGO) Q2 EPS Rises 7.5%
Via The Motley Fool
Topics Earnings Economy Supply Chain
Perrigo Co PLC (NYSE:PRGO) Q2 2025 Earnings Miss Estimates, Shares Drop 6% in Pre-Market Trading
Perrigo's Q2 2025 earnings missed revenue and EPS estimates, causing a 6% pre-market drop. Strategic initiatives like divestments and global growth were overshadowed by weak results. 
Via Chartmill
Topics Earnings
Earnings Scheduled For August 6, 2025
 
Via Benzinga
A Peek at Perrigo's Future Earnings
 
Via Benzinga
These 3 Dividend Stocks Combine Strong Yields With Upside
These three high-yield dividend stocks are well-positioned to deliver a strong return, making them attractive to both income and growth-oriented investors 
Via MarketBeat
Topics World Trade
Earnings Scheduled For May 7, 2025
 
Via Benzinga
Earnings Scheduled For February 27, 2025
 
Via Benzinga
Earnings Scheduled For February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. 
Via Benzinga
Perrigo Supports Customers through Tough Times, Supporting Shareholders through Changes
 
Via Benzinga
Trump Tariffs Could Have 'Significant Impact' On Perrigo Earnings, Says JP Morgan
JP Morgan warns tariffs could impact Perrigo's near-term earnings, though efficiencies and price hikes may ease pressure by 2026. 
Via Benzinga
Topics Government World Trade
Nasdaq, S&P 500 Head for Worst Weekly Losses Since September
Stocks are higher midday, getting a much-needed lift from this morning's inflation data that came in line with estimates. 
Via Talk Markets
Topics Economy Stocks Stocks / Equities
Perrigo Outlines 2025 Growth Plans, Projects Sales Boost And Margin Expansion By 2027
Perrigo Company shares surged after issuing financial targets for 2025 & 2025-2027 on investor day. Expect sales growth, EPS, and margin expansion. 'Three-S' plan will enhance cash flow & shareholder... 
Via Benzinga
These stocks are gapping in today's session
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday. 
Via Chartmill
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
JP Morgan highlights 2025 growth prospects for biopharma, animal health, and specialty pharma stocks. Key picks include Eli Lilly, Zoetis, and Bristol-Myers Squibb. 
Via Benzinga
JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
JP Morgan assesses the specialty pharma sector, highlighting robust fundamentals and new product excitement. Key focus on Teva, Organon, and Viatris. 
Via Benzinga
PRGO Stock Earnings: Perrigo Beats EPS, Misses Revenue for Q2 2024
PRGO stock results show that Perrigo beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Abbott Labs (ABT) Stock Falls on Baby Formula Ruling. What to Know.
ABT stock is in focus on ruling news. Abbott faced a suit last year over the closing of its Michigan plant resulting in a formula shortage. 
Via InvestorPlace
AbbVie Appeals To Supreme Court Over Attorney-Client Privilege In 'Long-Standing' AndroGel Case
AbbVie petitions the U.S. Supreme Court to protect its corporate records, arguing a lower court ruling threatens attorney-client privilege. 
Via Benzinga
$20M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying
 
Via Benzinga
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
 
Via Benzinga
PRGO Stock Earnings: Perrigo Beats EPS, Misses Revenue for Q1 2024
PRGO stock results show that Perrigo beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Disney To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
CVS Health's Zero-Cost Coverage Paves Way For OTC Birth Control Access
CVS Health expands coverage to include the first OTC birth control pill in the U.S., offering accessible contraception without prescription costs. Learn about this pivotal shift in reproductive... 
Via Benzinga
Hidden Gems: 3 Market Underdogs to Buy at Rock-Bottom Prices
While these underdogs stocks might not be on everyone’s radar, they may offer surprisingly robust upside potential. 
Via InvestorPlace
Around $2M Bet On Tile Shop Holdings? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed higher on Thursday, there were a few notable insider trades. 
Via Benzinga
Stocks Mixed As Consumer Confidence Falls
Stocks are mixed midday, after the most recent batch of economic data. 
Via Talk Markets
OTC Medicine Player Perrigo Outlines Three-Year Cost Saving Plan, Posts Mixed Q4 Earnings
Perrigo Q4 2023 net sales reach $1.2 billion, up 0.1% YoY. Explore Project Energize for long-term growth. 
Via Benzinga
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings. 
Via Benzinga
Insiders bet big on these turnaround stocks
Insiders are buying Bally's, Delcath Systems and Perrigo while their shares are at historic lows and catalysts are ahead. 
Via MarketBeat
Topics Economy Initial Public Offering
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.